Köpenysejtes limfóma: vizsgálatok itt: Görögország

1 trial · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 1. fázisTaking people
  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Where

  Athens, Patras, Thessaloniki

  Életkor

  18 év and over

  People

  85 worldwide

  Run by

  Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  See details and how to joinNCT06980116 · EU 2024-516869-36-00